Agios Pharmaceuticals Awarded Funding From Accelerate Brain Cancer Cure (ABC2) to Support Research into Novel Therapeutics and Diagnostics for Brain Cancer Read more about Agios Pharmaceuticals Awarded Funding From Accelerate Brain Cancer Cure (ABC2) to Support Research into Novel Therapeutics and Diagnostics for Brain Cancer
Agios Pharmaceuticals Appoints William Kaelin Jr., M.D., to Scientific Advisory Board Read more about Agios Pharmaceuticals Appoints William Kaelin Jr., M.D., to Scientific Advisory Board
Celgene Corporation and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism Read more about Celgene Corporation and Agios Pharmaceuticals Announce Global Strategic Collaboration to Advance Unique Science of Cancer Metabolism
Agios Scientists Present IDH1 Data at 2010 AACR Meeting Read more about Agios Scientists Present IDH1 Data at 2010 AACR Meeting
Agios Appoints John Maraganore, Ph.D., to Board of Directors Read more about Agios Appoints John Maraganore, Ph.D., to Board of Directors
Agios Creates Expanded Scientific Advisory Role for Lewis Cantley, Ph.D. Read more about Agios Creates Expanded Scientific Advisory Role for Lewis Cantley, Ph.D.
Agios Appoints Scott Biller, Ph.D., Industry Leader and Drug Developer, as Chief Scientific Officer Read more about Agios Appoints Scott Biller, Ph.D., Industry Leader and Drug Developer, as Chief Scientific Officer
Agios Awarded Two Federal Grants to Advance Cancer Metabolism Focused Therapeutics Read more about Agios Awarded Two Federal Grants to Advance Cancer Metabolism Focused Therapeutics
Agios Announces Cancer Cell Publication of Research Illuminating Link between Cancer Metabolism and Epigenetics Read more about Agios Announces Cancer Cell Publication of Research Illuminating Link between Cancer Metabolism and Epigenetics
Agios Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference Read more about Agios Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference